AGM/EGMApr 28, 2026, 04:13 PM
AVBP Sets Annual Meeting for June 18; Elects Directors, Ratifies Auditor
AI Summary
ArriVent BioPharma, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 18, 2026. Key proposals include the election of three directors to serve three-year terms and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026. The board of directors recommends approval for both proposals. The filing also detailed significant beneficial ownership, with Infinitum Asset Management, LLC, Hillhouse Investment Management, Ltd., and Suvretta Capital Management, LLC being among the largest holders.
Key Highlights
- Annual Meeting to be held virtually on June 18, 2026, at 12:00 p.m. ET.
- Stockholders to elect three directors for three-year terms expiring in 2029.
- Stockholders to ratify PricewaterhouseCoopers LLP as independent auditor for 2026.
- Record date for voting is April 21, 2026, with 46,368,442 shares outstanding.
- Infinitum Asset Management, LLC is largest beneficial owner with 8.89% of shares.
- Hillhouse Investment Management, Ltd. holds 8.47% of common stock.
- Suvretta Capital Management, LLC holds 7.36% of common stock.
- FMR LLC holds 7.35% of common stock.
Price Impact
More from AVBP